Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

BLRXBLRX
5 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in BIOLINE RX LIMITED

BNP PARIBAS FINANCIAL MARKETS holds 500 shares of BLRX (BIOLINE RX LIMITED), worth $1,550 as of 2026-Q2. The position was decreased (-72.2% shares).

Current Value

$1,550

Current Shares

500

Total Value Change

-$3,624

Total Shares Change

-1,248

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
500
-72.2%
$1,5500.0%$3.12
0
2026-Q1
Increased
1,800
+20.0%
$4,1400.0%$2.81
12
2025-Q4
New
1,500
-
$4,1550.0%$2.87
22
2025-Q2
Exited
0
-100.0%
$00.0%$4.43
0
2025-Q1
New
1,748
-
$5,1740.0%$3.05
23

Other major holders of BLRX: CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SIMPLEX TRADING, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used